|Articles|April 27, 2015
ICON Launches Electronic Informed Consent
ICON has announced Firecrest eConsent, an electronic informed consent solution that incorporates recommendations from the FDA¹s recent draft guidance on informed consent.
Advertisement
ICON has announced Firecrest eConsent, an electronic informed consent solution that incorporates recommendations from the FDA¹s recent
The e-Consent solution is a component of ICON¹s new informatics hub designed to enhance the engagement of patient populations in the drug development process. The solution employs videos and visual aids to assist in the explanation of complex scientific concepts and medical terms found in trial protocols.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
Breaking the Efficacy Ceiling in IBD and Beyond
5